Literature DB >> 17827883

Factors concerning early embryonic death in thoroughbred mares in South Korea.

Young-Jin Yang1, Gil-Jae Cho.   

Abstract

A total of 384 Thoroughbred mares were investigated to determine and evaluate the features of early embryonic death at nine equine farms on Jeju Island, South Korea, from 2001 to 2003. Overall, 771 matings for 384 mares resulted in 376 pregnancies 15 days after ovulation. Subsequently, 12.2% (46/376) of these early conceptuses were lost within 45 days after ovulation. Furthermore, about three quarters of the 46 embryonic deaths occurred between 16 and 25 days after ovulation. The incidence of embryonic death was highest in the barren (17.2%), more than 15 years old (15.4%), and more than 10 parities (18.2%) groups compared with the other groups (9.1-16.9%). Mares mated in March, April, and during the first estrus postpartum had higher embryonic death rates, (19.6%, 17.2%, and 24.6%, respectively). Mares with abnormal fluid and cysts in the uterus (18.0%) or multiple embryonic vesicles (23.1%) had higher embryonic death rates than those with normal uterine conditions (9.8%) or single embryonic vesicles (10.5%). The condition of mares, such as breeding condition and the environment of the embryo or fetus, are the major factors in relation to occurrence of early embryonic death.

Entities:  

Mesh:

Year:  2007        PMID: 17827883     DOI: 10.1292/jvms.69.787

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  2 in total

1.  Foaling rate of mares that were rebred after pregnancy loss in Hidaka, Japan.

Authors:  Daisuke Miyakoshi; Fumio Sato; Harutaka Murase; Yuji Inoue; Mitsumori Shikichi; Katsuroku Iwata; Kazuhiko Okai; Katsumi Ito; Yasuo Nambo
Journal:  J Equine Sci       Date:  2017-12-16

Review 2.  Canine and feline pregnancy loss due to viral and non-infectious causes: a review.

Authors:  J Verstegen; G Dhaliwal; K Verstegen-Onclin
Journal:  Theriogenology       Date:  2008-06-10       Impact factor: 2.740

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.